Researcher.Life Logo

Current Radiopharmaceuticals : Impact Factor & More

eISSN: 1874-4729pISSN: 1874-4710

Key Metrics

CiteScore
5.8
H-Index
30
Impact Factor
< 5
SJR
Q3Pharmacology
SNIP
1.03
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Radiopharmaceuticals

Current Radiopharmaceuticals Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Radiopharmaceuticals ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your researchless than 30 sec
Free Report

Recently Published Papers in Current Radiopharmaceuticals

Evaluating the Effectiveness of Geant4 Software in Measuring the Damage Caused by Ti48 Ion Radiation on Nerve Cells, in Comparison to the Biophysical Model and Empirical Data.
  • 1 Dec 2025
  • Current radiopharmaceuticals
Role of the p53/miR-34a/SIRT1 Feedback Loop in Metformin-induced Radiosensitivity of Colorectal Cancer Cells.
  • 1 Dec 2025
  • Current radiopharmaceuticals
Real-world Data on Intermediate-risk Differentiated Thyroid Cancer Biochemical Response to 3700 or 5550 MBq of [131I]Sodium Iodide.
  • 1 Dec 2025
  • Current radiopharmaceuticals
Nuclear Nanomedicines: Utilization of Radiolabelling Strategies, Drug Formulation, Delivery, and Regulatory Aspects for Disease Management.
  • 1 Dec 2025
  • Current radiopharmaceuticals
RNA Binding Proteins are Pivotal Regulators of Cancer Radioresistance and Potential Targets for Preventing Tumor Recurrence.
  • 1 Dec 2025
  • Current radiopharmaceuticals
Acknowledgement to Reviewers
  • 1 Dec 2025
  • Current Radiopharmaceuticals
Evaluating the Effectiveness of Geant4 Software in Measuring the Damage Caused by Ti48 Ion Radiation on Nerve Cells, in Comparison to the Biophysical Model and Empirical Data.
  • 1 Dec 2025
  • Current radiopharmaceuticals
Role of the p53/miR-34a/SIRT1 Feedback Loop in Metformin-induced Radiosensitivity of Colorectal Cancer Cells.
  • 1 Dec 2025
  • Current radiopharmaceuticals
Real-world Data on Intermediate-risk Differentiated Thyroid Cancer Biochemical Response to 3700 or 5550 MBq of [131I]Sodium Iodide.
  • 1 Dec 2025
  • Current radiopharmaceuticals
Nuclear Nanomedicines: Utilization of Radiolabelling Strategies, Drug Formulation, Delivery, and Regulatory Aspects for Disease Management.
  • 1 Dec 2025
  • Current radiopharmaceuticals
RNA Binding Proteins are Pivotal Regulators of Cancer Radioresistance and Potential Targets for Preventing Tumor Recurrence.
  • 1 Dec 2025
  • Current radiopharmaceuticals
Acknowledgement to Reviewers
  • 1 Dec 2025
  • Current Radiopharmaceuticals
View all papers for this journal

FAQs on Current Radiopharmaceuticals

Global Journal Library:

Editage Plus logo

Cactus Communications Services Pte Ltd
20 McCallum Street, #19-01, Tokio Marine Centre, Singapore 069046

We are with you every step of the way as you achieve your dreams - publication, everything that precedes it, and everything that comes after. You are much more than your last research project. It’s time you got more.

Instagram icon

USEFUL LINKS

EXCITED ABOUT RESEARCHER.LIFE?

We are always looking for inspiration, feedback, and collaborators

Write to us

Copyright 2025 Cactus Communications. All rights reserved.

Privacy PolicyCookies PolicyTerms of UseCareers
Check if your manuscript is a good match for
undefined

Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript


word doc icon
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages

Do not have a manuscript right now? Use an abstract or summary

Your document is 100% secure & confidential

We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified

What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations